Cargando…

NAFLD‐related hepatocellular carcinoma: The growing challenge

Hepatocellular carcinoma (HCC) is a common cause of cancer‐related mortality and morbidity worldwide. With the obesity pandemic, NAFLD‐related HCC is contributing to the burden of disease exponentially. Genetic predisposition and clinical risk factors for NAFLD‐related HCC have been identified. Cirr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shah, Pir Ahmad, Patil, Rashmee, Harrison, Stephen A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970023/ https://www.ncbi.nlm.nih.gov/pubmed/35478412 http://dx.doi.org/10.1002/hep.32542

Ejemplares similares

Immunotherapy for NAFLD and NAFLD-related hepatocellular carcinoma
por: Jeong, Seogsong, et al.
Publicado: (2023)

Proton Pump Inhibitors and Clostridium Difficile Infection: Are We Propagating an Already Rapidly Growing Healthcare Problem?
por: Patil, Rashmee, et al.
Publicado: (2013)

The Emerging Factors and Treatment Options for NAFLD-Related Hepatocellular Carcinoma
por: Zhang, Chunye, et al.
Publicado: (2021)

An Overview of Hepatocellular Carcinoma Surveillance Focusing on Non-Cirrhotic NAFLD Patients: A Challenge for Physicians
por: Cespiati, Annalisa, et al.
Publicado: (2023)

Characterizing the mechanism behind the progression of NAFLD to hepatocellular carcinoma
por: Nahon, Pierre, et al.
Publicado: (2020)

Prevalence of the Absence of Cirrhosis in Subjects with NAFLD-Associated Hepatocellular Carcinoma
por: Castellana, Marco, et al.
Publicado: (2021)

Altered serum acylcarnitine profile is associated with the status of nonalcoholic fatty liver disease (NAFLD) and NAFLD-related hepatocellular carcinoma
por: Enooku, Kenichiro, et al.
Publicado: (2019)

Growing Evidence of Exosomal MicroRNA-Related Metastasis of Hepatocellular Carcinoma
por: Sun, Wenbing, et al.
Publicado: (2020)

Hepatocellular carcinoma in nonalcoholic fatty liver disease: A growing challenge
por: Mattos, Ângelo Z, et al.
Publicado: (2021)

Screening for NAFLD—Current Knowledge and Challenges
por: Forlano, Roberta, et al.
Publicado: (2023)

Senescence in HBV-, HCV- and NAFLD- Mediated Hepatocellular Carcinoma and Senotherapeutics: Current Evidence and Future Perspective
por: Giannakoulis, Vassilis G., et al.
Publicado: (2021)

Sex difference in liver diseases: How preclinical models help to dissect the sex-related mechanisms sustaining NAFLD and hepatocellular carcinoma
por: Smiriglia, Alfredo, et al.
Publicado: (2023)

The Growing Skyline of Advanced Hepatocellular Carcinoma Treatment: A Review
por: Schipilliti, Francesca Matilde, et al.
Publicado: (2021)

METTL3 drives NAFLD-related hepatocellular carcinoma and is a therapeutic target for boosting immunotherapy
por: Pan, Yasi, et al.
Publicado: (2023)

Novel biomarker genes for the prediction of post-hepatectomy survival of patients with NAFLD-related hepatocellular carcinoma
por: Song, Yuting, et al.
Publicado: (2023)

Hepatocellular carcinoma is the most common liver-related complication in patients with histopathologically-confirmed NAFLD in Japan
por: Akuta, Norio, et al.
Publicado: (2018)

Challenges of advanced hepatocellular carcinoma
por: Colagrande, Stefano, et al.
Publicado: (2016)

NAFLD polygenic risk score and risk of hepatocellular carcinoma in an East Asian population
por: Thomas, Claire E., et al.
Publicado: (2022)

The growing threat of non-alcoholic fatty liver disease-related hepatocellular carcinoma
por: Teng, Margaret L. P., et al.
Publicado: (2022)

NAFLD in the Elderly
por: Alqahtani, Saleh A, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease and diabetes mellitus as growing aetiologies of hepatocellular carcinoma
por: Talamantes, Stephanie, et al.
Publicado: (2023)

NAFLD and liver transplantation: Disease burden, current management and future challenges
por: Burra, Patrizia, et al.
Publicado: (2020)

Pediatric hepatocellular carcinoma: challenges and solutions
por: Schmid, Irene, et al.
Publicado: (2017)

Resection of NAFLD/NASH-related Hepatocellular Carcinoma (HCC): Clinical Features and Outcomes Compared with HCC Due to Other Etiologies
por: Pal Chaudhary, Surendra, et al.
Publicado: (2023)

The Role of Vitamin E in the Treatment of NAFLD
por: Perumpail, Brandon J., et al.
Publicado: (2018)

Serine palmitoyltransferase long chain subunit 3 is associated with hepatocellular carcinoma in patients with NAFLD
por: Ijuin, Sho, et al.
Publicado: (2022)

Impact of NAFLD on clinical outcomes in hepatocellular carcinoma treated with sorafenib: an international cohort study
por: Howell, Jessica, et al.
Publicado: (2022)

Endocuff-Assisted Colonoscopy—A Novel Accessory in Improving Adenoma Detection Rate: A Review of the Literature
por: Patil, Rashmee, et al.
Publicado: (2016)

Recurrence of fatty liver disease following liver transplantation for NAFLD-related cirrhosis: Current status and challenges
por: Dooghaie Moghadam, Arash, et al.
Publicado: (2020)

NAFLD-Related Hepatocarcinoma: The Malignant Side of Metabolic Syndrome
por: Michelotti, Anna, et al.
Publicado: (2021)

Challenge and Hope in Radiotherapy of Hepatocellular Carcinoma
por: Seong, Jinsil
Publicado: (2009)

Characterization of two types of intranuclear hepatocellular inclusions in NAFLD
por: Schwertheim, Suzan, et al.
Publicado: (2020)

Hepatocellular carcinoma in elderly patients: challenges and solutions
por: Brunot, Angélique, et al.
Publicado: (2016)

Hepatocellular carcinoma: early-stage management challenges
por: Erstad, Derek J, et al.
Publicado: (2017)

Intratumor Heterogeneity in Hepatocellular Carcinoma: Challenges and Opportunities
por: Kalasekar, Sharanya Maanasi, et al.
Publicado: (2021)

Targeting T Cell Subtypes for NAFLD and NAFLD-Related HCC Treatment: An Opinion
por: Zhang, Chunye, et al.
Publicado: (2021)

The rs599839 A>G Variant Disentangles Cardiovascular Risk and Hepatocellular Carcinoma in NAFLD Patients
por: Meroni, Marica, et al.
Publicado: (2021)

Endoscopic Ultrasound-Guided Radiofrequency Ablation of the Pancreatic Tumors: A Promising Tool in Management of Pancreatic Tumors
por: Changela, Kinesh, et al.
Publicado: (2016)

Advances and challenges in laparoscopic surgery in the management of hepatocellular carcinoma
por: Ziogas, Ioannis A, et al.
Publicado: (2017)

Association between Hepatic Oxidative Stress Related Factors and Activation of Wnt/β-Catenin Signaling in NAFLD-Induced Hepatocellular Carcinoma
por: Hamaguchi, Kota, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dv5eqeg58avjd8es72lhjdcf7n